The Johns Hopkins University Applied Physics Laboratory (APL) of Laurel, Md., has licensed a nationally and internationally patented formula for eye drops that could speed healing and prevent cloudiness after laser vision-correction surgery.
The exclusive licensing agreement allows Illinois-based AdPharma, Inc. to develop, seek regulatory approval for and market the drops, invented by APL researcher David Silver with collaborators Adrienne Csutak, András Berta and József Tőzsér of the University Medical School of Debrecen, Hungary.
Studies have shown that nearly one in 10 laser-surgery patients develops hazy vision several months after the operation. In some cases the effects can last a year or longer. The APL-developed drops would prevent this “haze” from forming in the cornea.source: Johns Hopkins University